Skip to main content

Dr. James M. Mobley, M.D.

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
11
In the NPI registry since
2015
Medicare patients seen, 2024
619

Licensed in Texas since 2021, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2015Medical school: Texas A & M University System, Hsc, College of Medicine
  • 2015Registered with an NPI (national billing number; not a license date)

Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    TX license T3827 (first issued 2021; active) · KY license 52720
  • Internal Medicine Physician
    TX license T3827 (first issued 2021; active)
  • Medical Oncology Physician
    TX license T3827 (first issued 2021; active)
  • Student in an Organized Health Care Education/Training Program

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
619
Services billed
163,244
Patients’ average age
76
Most frequent Medicare services, 2023
ServiceTimesPatients
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)30,60044
Injection, oxaliplatin, 0.5 mg14,36013
Injection, pembrolizumab, 1 mg10,00019
Injection, iron sucrose, 1 mg7,20020
Injection, paclitaxel, 1 mg5,33612
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml4,69551
Injection, darbepoetin alfa, 1 microgram (non-esrd use)3,72014
Injection, bortezomib, 0.1 mg3,57015
Injection, dexamethasone sodium phosphate, 1 mg2,67381
Injection, granisetron hydrochloride, 100 mcg1,04026

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 21 companies reported 58 payments worth $1,171 in total to this clinician.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Texas →

Other Hematology & Oncology clinicians in Plano

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 24, 2022), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1184018285. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.